Inactive Instrument

Quotes Kadimastem OTC Markets

Stocks

Delayed OTC Markets 14:13:59 2025-03-18 EDT			5-day change	1st Jan Change
5.060 ^USD	-0.78%		+153.00%	+690.13%

07-30	NewcelX Ltd. announced that it expects to receive $1.399991 million in funding	CI
07-15	NewcelX Obtains Patent in Brazil for Potential Type 1 Diabetes Treatment	MT

Stock exchange

OTC Markets KMSTF - $ - 0 $

Markets		Price	Change	Volumes
Nasdaq	NCEL	3.330USD	+4.39%	8.9K $
CBOE	NCEL	3.260USD	-6.86%	1.39K $

1 day

-0.78%

markets

Capital turnover ratio

Float rotation

0.01

Market Cap (USD)

Net sales (ILS)

Net sales (USD)

Number of employees

Sales / Employee (ILS)

Sales / Employee (USD)

Moving average 5 days

2.69

Moving average 20 days

1.34

RSI 9 days

80.53

RSI 14 days

79.46

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KADIMASTEM	-	0.00%	-	-	-
LONZA GROUP AG	-1.78%	-1.68%	+1.99%	+13.84%	48.42B
REVOLUTION MEDICINES, INC.	+0.85%	-0.70%	+465.55%	+579.03%	43.66B
BEONE MEDICINES AG	-2.40%	-0.23%	+12.20%	+70.22%	39.51B
IQVIA HOLDINGS INC.	-2.01%	-0.85%	+24.95%	+7.51%	38.95B
CELLTRION, INC.	-0.50%	+0.85%	+20.60%	+49.65%	32.61B
MEDPACE HOLDINGS, INC.	-0.59%	-2.06%	+26.13%	+117.79%	16.15B
ASCENDIS PHARMA A/S	+0.38%	-3.23%	-	-	16.32B
EUROFINS SCIENTIFIC SE	+0.49%	+0.92%	+4.32%	+22.16%	14.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.43%	+4.70%	+79.75%	+29.11%	13.37B
Average	-0.68%	+0.49%	+79.44%	+111.17%	26.32B
Weighted average by Cap.	-0.91%	+0.59%	+97.63%	+134.68%